The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM
NCT02582840
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG:
Dapagliflozin 5mg
DRUG:
Dapagliflozin 10mg
DRUG:
Placebo tablet
Sponsor
AstraZeneca